跳到正文
原文
MedTech Dive 器械媒体· Nick Paul Taylor·· 11 天前AI 评分35

Labcorp 完成对 Millennium Health 的收购

Labcorp completes $375M Millennium Health takeover

AI 导读

Labcorp 完成了对 Millennium Health 的收购,交易价值 2.45 亿美元,外加最高 1.3 亿美元的里程碑付款。此次收购增强了 Labcorp 的毒理学能力,并扩大了其地理足迹。Labcorp CEO 表示,此次收购将使其在之前缺乏强大业务的地区更具竞争力。

正文

An article from site logo

Dive Brief

The deal, which includes a $245 million upfront fee, expands the geographic reach of Labcorp’s drug testing business.

Published Nov. 9, 2026

By

A picture of the exterior of a Labcorp building.

The exterior of a Labcorp building. The testing services provider has made a series of acquisitions this year. Courtesy of Labcorp

This audio is auto-generated. Please let us know if you have feedback.

Dive Brief:

  • Labcorp has completed its takeover of accredited specialty laboratory Millennium Health, the company said last week. 
  • The takeover, which Labcorp struck last month, is worth $245 million upfront plus up to $130 million in milestone payments. 
  • Labcorp bought Millennium to strengthen its toxicology capabilities and expand its geographic footprint.

Dive Insight:

Millennium offers urine- and oral-fluid-based tests for prescription, over-the-counter and illicit drugs. Labcorp already provides drug testing to help physicians monitor patients who are prescribed controlled substances, have a substance use disorder or are exposed to drugs unintentionally. 

CEO Adam Schechter discussed Labcorp’s drug testing unit on an earnings call late last month, telling investors that “we do very well in that business.” Buying Millennium increases Labcorp’s presence in parts of the country where it previously lacked a strong footprint.  

“It’s a business we know how to run, it’s a business we’ve been involved in for many years and it just expands our geographic footprint and enables us to be more competitive, improve access to parts of the country that we don’t have as much access to as of today,” Schechter said. 

Labcorp did not disclose the financial terms of the takeover when it first announced the agreement. However, a subsequent financial regulatory filing revealed the size of the upfront fee, which Labcorp paid in cash, and potential payments tied to the outcome of “specified future events.”

The Millennium takeover was one of four deals Labcorp struck in September and October. Over those months, the company unveiled deals to buy MLM Medical Labs, laboratory testing businesses from Opko Health subsidiary BioReference Health and Myriad Genetics’ prenatal health testing business. 

Asked by an analyst about the spate of takeovers, Schechter said, “You can't control the exact timing of deals, but when the pipeline is strong, the deals will come.” Labcorp has other deals in the pipeline, which remains strong, Schechter said. The CEO cited the Protecting Access to Medicare Act as a driver of deal opportunities. 

“It ... increases the pipeline for business development,” Schechter said. “I think smaller hospital laboratories, regional/local laboratories, they're going to struggle a lot with PAMA, and it really does cause them to rethink about their business.”

来源:MedTech Dive 器械媒体 · medtechdive.com